205 related articles for article (PubMed ID: 35264881)
1. A Nomogram for Predicting In-Stent Restenosis Risk in Patients Undergoing Percutaneous Coronary Intervention: A Population-Based Analysis.
Luo Y; Tan N; Zhao J; Li Y
Int J Gen Med; 2022; 15():2451-2461. PubMed ID: 35264881
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.
He W; Xu C; Wang X; Lei J; Qiu Q; Hu Y; Luo D
BMC Cardiovasc Disord; 2021 Sep; 21(1):435. PubMed ID: 34521385
[TBL] [Abstract][Full Text] [Related]
3. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.
Gai MT; Zhu B; Chen XC; Liu F; Xie X; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
Lipids Health Dis; 2021 Sep; 20(1):118. PubMed ID: 34587955
[TBL] [Abstract][Full Text] [Related]
4. Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease.
Xi H; Liu J; Xu T; Li Z; Mou X; Jin Y; Xia S
Front Cardiovasc Med; 2023; 10():1117915. PubMed ID: 36970340
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation.
Luo Y; Cui S; Zhang C; Huang R; Zhao J; Su K; Luo D; Li Y
Int J Gen Med; 2022; 15():1733-1742. PubMed ID: 35221713
[TBL] [Abstract][Full Text] [Related]
6. New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent.
Wang JL; Qin Z; Wang ZJ; Shi DM; Liu YY; Zhao YX; Yang LX; Cheng WJ; Zhou YJ
J Geriatr Cardiol; 2018 Feb; 15(2):137-145. PubMed ID: 29662507
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of COPD History on In-Stent Restenosis in Coronary Arteries Following Percutaneous Coronary Intervention.
Hou L; Su K; Zhao J; Li Y
Int J Gen Med; 2023; 16():3977-3984. PubMed ID: 37670929
[TBL] [Abstract][Full Text] [Related]
8. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X
BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149
[TBL] [Abstract][Full Text] [Related]
9. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents.
Wu XA; Xie G; Li XQ; Wu HT; Wang X
Clin Chim Acta; 2018 Apr; 479():20-24. PubMed ID: 29305846
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
Zeng M; Yan X; Wu W
BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
[TBL] [Abstract][Full Text] [Related]
11. Investigation Into the Risk Factors Related to In-stent Restenosis in Elderly Patients With Coronary Heart Disease and Type 2 Diabetes Within 2 Years After the First Drug-Eluting Stent Implantation.
Yi M; Tang WH; Xu S; Ke X; Liu Q
Front Cardiovasc Med; 2022; 9():837330. PubMed ID: 35669469
[TBL] [Abstract][Full Text] [Related]
12. [The predictive value of epicardial adipose tissue and inflammatory factors for in-stent restenosis].
Zhou QN; Lin WH; Jing R; Liu JJ; Shi HY; Yang RF; Gao P; Zhang Y
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(47):3732-3736. PubMed ID: 31874499
[No Abstract] [Full Text] [Related]
13. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study.
Zhang L; Wang Y; Zhang Z; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
BMC Cardiovasc Disord; 2021 Sep; 21(1):438. PubMed ID: 34525967
[TBL] [Abstract][Full Text] [Related]
14. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
15. Intravascular Ultrasound and Angiographic Predictors of In-Stent Restenosis of Chronic Total Occlusion Lesions.
Kang J; Cho YS; Kim SW; Park JJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Youn TJ; Chae IH; Choi DJ
PLoS One; 2015; 10(10):e0140421. PubMed ID: 26465755
[TBL] [Abstract][Full Text] [Related]
16. Use of the neutrophil to lymphocyte ratio for prediction of in-stent restenosis in bifurcation lesions.
Balli M; Taşolar H; Çetin M; Tekin K; Çağliyan ÇE; Türkmen S; Yilmaz M; Elbasan Z; Şahin DY; Çayli M
Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1866-73. PubMed ID: 26044233
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Stent Restenosis in Han and Uygur Patients with Coronary Heart Disease after PCI in the Xinjiang Region.
Wang J; Yang Y; Zhang L; He P; Mu H
Cardiol Res Pract; 2022; 2022():7845108. PubMed ID: 35958295
[TBL] [Abstract][Full Text] [Related]
18. The Early Predictive Value of Circulating Monocytes and Eosinophils in Coronary DES Restenosis.
Li S; Qiu H; Lin Z; Fan L; Guo Y; Zhang Y; Chen L
Front Cardiovasc Med; 2022; 9():764622. PubMed ID: 35274009
[TBL] [Abstract][Full Text] [Related]
19. Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.
Liu J; Liu Y; Jia K; Huo Z; Huo Q; Liu Z; Li Y; Han X; Wang R
Medicine (Baltimore); 2018 Apr; 97(17):e0366. PubMed ID: 29702981
[TBL] [Abstract][Full Text] [Related]
20. Development, validation and visualization of a web-based nomogram for predicting risk of new-onset diabetes after percutaneous coronary intervention.
Zhu M; Li Y; Wang W; Liu Y; Tong T; Liu Y
Sci Rep; 2024 Jun; 14(1):13652. PubMed ID: 38871809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
